Transplant Laboratory, Department of General-, Visceral-, and Transplantation Surgery, Hannover Medical School, Hannover, Germany.
Institute of Farm Animal Genetics, Friedrich-Loeffler-Institut, Mariensee, Germany.
Xenotransplantation. 2019 Jul;26(4):e12523. doi: 10.1111/xen.12523. Epub 2019 May 9.
Differences in quality and strength of immune responses between individuals are mainly due to polymorphisms in major histocompatibility complex (MHC) molecules. Focusing on MHC class-II, we asked whether the intensity of human anti-pig T-cell responses is influenced by genetic variability in the human HLA-DRB1 and/or the porcine SLA-DRB1 locus.
ELISpot assays were performed using peripheral blood mononuclear cells (PBMCs) from 62 HLA-DRB1-typed blood donors as responder and the porcine B cell line L23 as stimulator cells. Based on the frequency of IFN-γ-secreting cells, groups of weak, medium, and strong responder individuals were defined. Mixed lymphocyte reaction (MLR) assays were performed to study the stimulatory capacity of porcine PBMCs expressing different SLA-DRB1 alleles.
Concerning the MHC class-II configuration of human cells, we found a significant overrepresentation of HLA-DRB101 alleles in the medium/strong responder group as compared to individuals showing weak responses to stimulation with L23 cells. Evaluation of the role of MHC class-II variability in porcine stimulators revealed that cells expressing SLA-DRB106 alleles triggered strong proliferation in approximately 70% of humans. Comparison of amino acid sequences indicated that strong human anti-pig reactivity may be associated with a high rate of similarity between human and pig HLA/SLA-DRB1 alleles.
Variability in human and porcine MHC determines the intensity of individual human anti-pig T-cell responses. MHC typing and cross-matching of prospective recipients of xenografts and donor pigs could be relevant to select for donor-recipient combinations with minimal anti-porcine immunity.
个体之间免疫反应的质量和强度的差异主要归因于主要组织相容性复合体 (MHC) 分子的多态性。本研究聚焦于 MHC Ⅱ类,旨在探讨人类抗猪 T 细胞反应的强度是否受人类 HLA-DRB1 和/或猪 SLA-DRB1 基因座遗传多态性的影响。
采用外周血单核细胞 (PBMC) 作为反应细胞,以猪 B 细胞系 L23 作为刺激细胞,通过 ELISpot 法检测 62 名 HLA-DRB1 基因分型的献血者的抗猪 T 细胞反应。根据 IFN-γ分泌细胞的频率,将个体分为弱、中、强反应组。采用混合淋巴细胞反应 (MLR) 法检测表达不同 SLA-DRB1 等位基因的猪 PBMC 的刺激能力。
就人类细胞的 MHC Ⅱ类构型而言,与刺激 L23 细胞后表现出弱反应的个体相比,中/强反应组中 HLA-DRB101 等位基因的出现频率明显更高。评估 MHC Ⅱ类多态性在猪刺激物中的作用发现,表达 SLA-DRB106 等位基因的细胞可在约 70%的人类中引发强烈的增殖反应。氨基酸序列比较表明,强烈的人类抗猪反应可能与人类和猪 HLA/SLA-DRB1 等位基因之间的高相似率相关。
人类和猪 MHC 的变异性决定了个体抗猪 T 细胞反应的强度。对异种移植物受者和供体猪的 MHC 进行分型和交叉配型,可能有助于选择具有最小抗猪免疫性的供体-受者组合。